YCM
CPRX

Yousif Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Yousif Capital Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$986K Sell
31,371
-48
-0.2% -$1.42K 0.01% 1073
2026
Q1 		$778K Sell
31,419
-550
-2% -$13.1K 0.01% 1193
2025
Q4 		$747K Sell
31,969
-4,196
-12% -$93.5K 0.01% 1224
2025
Q3 		$712K Sell
36,165
-7,272
-17% -$150K 0.01% 1278
2025
Q2 		$943K Buy
43,437
+1,318
+3% +$31.1K 0.01% 1159
2025
Q1 		$1.02M Sell
42,119
-1,151
-3% -$25.9K 0.01% 1095
2024
Q4 		$903K Sell
43,270
-592
-1% -$12.7K 0.01% 1206
2024
Q3 		$872K Sell
43,862
-1,638
-4% -$30.4K 0.01% 1247
2024
Q2 		$705K Sell
45,500
-5,134
-10% -$79.9K 0.01% 1313
2024
Q1 		$807K Sell
50,634
-3,015
-6% -$45.4K 0.01% 1303
2023
Q4 		$902K Sell
53,649
-3,164
-6% -$43.3K 0.01% 1269
2023
Q3 		$664K Sell
56,813
-2,027
-3% -$27.1K 0.01% 1344
2023
Q2 		$791K Sell
58,840
-2,545
-4% -$36.6K 0.01% 1271
2023
Q1 		$1.02M Sell
61,385
-6,960
-10% -$115K 0.01% 1140
2022
Q4 		$1.27M Sell
68,345
-16,050
-19% -$247K 0.02% 1041
2022
Q3 		$1.08M Buy
+84,395
New +$1M 0.02% 1147

Other funds holding CPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Yousif Capital Management's CPRX Position: Q2 2026 in Review

Yousif Capital Management reduced its Catalyst Pharmaceutical (CPRX) stake by 0.15% in Q2 2026, selling an estimated $1.42K and leaving 31,371 shares worth $986K. The position accounts for 0.01% of the portfolio, ranked #1073.

Yousif Capital Management first reported a position in CPRX in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.27M in Q4 2022. 36 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Yousif Capital Management held 31,371 shares of Catalyst Pharmaceutical worth $986K as of Q2 2026.
  • Yousif Capital Management sold 48 Catalyst Pharmaceutical shares in Q2 2026, an estimated $1.42K.
  • Catalyst Pharmaceutical made up 0.01% of Yousif Capital Management's portfolio in Q2 2026, its #1073 holding.
  • Yousif Capital Management first reported a position in Catalyst Pharmaceutical in Q3 2022 and has held it in 16 quarters since.
  • Yousif Capital Management's Catalyst Pharmaceutical position peaked at $1.27M in Q4 2022.
  • 36 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.